Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (NASDAQ: SKIN) generates a steady flow of news at the intersection of medical technology, professional aesthetics, and beauty. As the parent of Hydrafacial, SkinStylus, and Keravive, the company issues regular updates on financial performance, science-backed innovation, provider partnerships, and corporate governance, giving investors and industry followers insight into how its skin health platform is evolving.
On this page, readers can follow earnings announcements and financial results, where BeautyHealth reports net sales, gross margin, adjusted EBITDA, delivery systems sold, and active install base across the Americas, Asia-Pacific, and EMEA. These releases often include management commentary on trends in device sales versus consumables, the performance of the recurring revenue stream, and changes in regional go-to-market strategies.
News coverage also highlights product and innovation updates, such as the launch of boosters like HydraFillic with Pep9 and references to Hydralock HA Booster, as well as insights from the company’s Skintuition Report, which explores consumer trends in modern skin health and aesthetics. Additional stories focus on initiatives like the Hydrafacial Advisory Councils and Ambassador Network, which bring together plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to guide product development, education, and clinical research.
Corporate and governance news includes executive appointments, board changes, and capital structure developments, such as the appointment of a new President and Chief Executive Officer, the addition of a new independent director, and updates related to convertible senior notes and charter amendments. For anyone tracking SKIN, this news feed offers a centralized view of the company’s operational progress, strategic priorities, and role in professional skin and scalp health.
The Beauty Health Company (NASDAQ:SKIN) has partnered with Organicell to develop a groundbreaking exosome booster targeting aging and inflammation. This innovative product will utilize Organicell's advanced exosome technology, harnessing over 300 cytokines and growth factors. With a rapid development process, the booster is expected to enhance Hydrafacial's offerings and will launch in early 2024. This collaboration capitalizes on co-creation, allowing the company to stay ahead in the skincare market by responding quickly to consumer demands for regenerative treatments.
The Beauty Health Company (NASDAQ:SKIN) has launched Hydrafacial Experience Centers in Paris and Singapore, expanding its training program for aestheticians to 13 locations across 10 countries. This move emphasizes the company's growth strategy in the high-potential EMEA and APAC markets. The new centers will feature Syndeo, the next-gen delivery system, furthering Hydrafacial's international rollout in 2023. The HFX training program, introduced in 2018, enhances provider skills, driving increased usage of Hydrafacial machines among trained aestheticians.
The Beauty Health Company (NASDAQ:SKIN) will host its first Investor Day on September 15, 2022, in New York City. The event features presentations from the executive committee, including President and CEO Andrew Stanleick, focusing on the company's strategy, addressable market, business model, and financial performance. The livestream starts at 9:00 a.m. ET and ends at 1:00 p.m. ET, with a live Q&A session included. A recording will be available post-event.
The Beauty Health Company (NASDAQ: SKIN) has appointed Jon Arnold as President, EMEA, and Stefanie Gebauer as President, Southeast Asia, to enhance its commercial leadership. These appointments are part of a strategic plan to capture growth in the global beauty-health market, leveraging the Hydrafacial brand. Arnold and Gebauer will oversee local teams and the rollout of Hydrafacial’s next-generation delivery system, Syndeo, across their regions in 2023. The company aims to increase market penetration and enhance brand awareness, tapping into the growing demand for innovative beauty technologies.
The Beauty Health Company (NASDAQ:SKIN) announced a partnership with Innerskin to introduce Hydrafacial at the Galeries Lafayette in Paris, located within La Wellness Galerie, set to open in September. This new wellness space spans 30,000 sq. ft. and is touted as Europe’s largest dedicated wellness area. The initiative aims to enhance customer experience by integrating beauty and wellness, driving foot traffic to the store, and positioning Hydrafacial treatments as essential within skincare plans.
The Beauty Health Company (NASDAQ: SKIN) reported all-time high quarterly net sales of $103.5 million for Q2 2022, marking a 55.7% increase YoY. Net income reached $7.9 million, contrasting sharply with a net loss of $139.4 million in Q2 2021. The company attributed strong results to the growing demand for its Hydrafacial products, raising its full-year net sales guidance to $340-$350 million. However, it also anticipates ongoing supply chain challenges and inflationary pressures may affect gross margins in the upcoming quarters.
The Beauty Health Company (NASDAQ: SKIN) has announced its inaugural Investor Day set for September 15, 2022, at 9:00 AM ET, in New York. The agenda includes discussions on the company's business model, market potential, financial performance, and future growth strategy, with a live Q&A session following. In-person attendance is by invitation only, and registration is required. A live webcast will also be offered on the company's investor relations website, with a recording available post-event. Beauty Health's HydraFacial brand leads in hydradermabrasion experiences globally.
The Beauty Health Company (NASDAQ:SKIN) will report its second quarter 2022 financial results on August 9, 2022, before market open. Following this, an investor conference call is scheduled for 8:30 a.m. Eastern Time. Investors and analysts can join the call via webcast, with a recording available three hours post-call. HydraFacial, the company's flagship brand, operates in over 90 countries with more than 21,000 delivery systems.
The Beauty Health Company (NASDAQ:SKIN) has expanded its partnership with Murad to launch the new Clarifying Booster for HydraFacial, designed for breakout-prone skin. This booster uses powerful ingredients like Salicylic Acid and Glycolic Acid for exfoliation, combined with Ginger Root Complex and Witch Hazel to soothe and purify the skin. This collaboration enhances the HydraFacial experience, offering a scientifically proven formulation that promotes clearer skin. The new booster complements existing Murad offerings and reinforces the brands' commitment to innovative skincare solutions.
The Beauty Health Company (NASDAQ:SKIN) announced the immediate appointment of Marla Beck, founder of Bluemercury, to its Board of Directors. Beck's extensive experience in leading growth-stage companies and her entrepreneurial accolades, including being an Ernst and Young Entrepreneur of the Year National Finalist, position her as a transformative addition to the board. Executive Chairman Brent Saunders expressed confidence in Beck’s ability to provide fresh perspectives and drive the company's growth as it seeks to enhance consumer self-confidence through its HydraFacial brand.
FAQ
What is the current stock price of The Beauty Health Company (SKIN)?
What is the market cap of The Beauty Health Company (SKIN)?
